Cervical Dystonia Therapeutics Market - Global Outlook and Forecast 2022-2028

March 2022 | 64 pages | ID: C4AE4FD088C9EN
Market Monitor Global

Abstracts

Cervical dystonia (or spasmodic torticollis) is the most common form of focal or localized dystonia. Neurological in origin, it is characterized by muscular spasms that cause abnormal movements of the neck, head and sometimes the shoulders. The neck muscles may contract, twist, tremble, or remain blocked in one direction, resulting in an awkward and uncomfortable posture.

This report contains market size and forecasts of Cervical Dystonia Therapeutics in Global, including the following market information:

Global Cervical Dystonia Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cervical Dystonia Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Botulinum Toxins Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cervical Dystonia Therapeutics include Allergan, Eisai, Ipsen Pharma, Merz Pharma and US WorldMeds, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cervical Dystonia Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cervical Dystonia Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cervical Dystonia Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Botulinum Toxins
• Drug
• Other

Global Cervical Dystonia Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cervical Dystonia Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Other

Global Cervical Dystonia Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cervical Dystonia Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cervical Dystonia Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cervical Dystonia Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Allergan
• Eisai
• Ipsen Pharma
• Merz Pharma
• US WorldMeds

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cervical Dystonia Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cervical Dystonia Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CERVICAL DYSTONIA THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Cervical Dystonia Therapeutics Market Size: 2021 VS 2028
2.2 Global Cervical Dystonia Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cervical Dystonia Therapeutics Players in Global Market
3.2 Top Global Cervical Dystonia Therapeutics Companies Ranked by Revenue
3.3 Global Cervical Dystonia Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Cervical Dystonia Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cervical Dystonia Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cervical Dystonia Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Cervical Dystonia Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cervical Dystonia Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cervical Dystonia Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Botulinum Toxins
  4.1.3 Drug
  4.1.4 Other
4.2 By Type - Global Cervical Dystonia Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Cervical Dystonia Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Cervical Dystonia Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Cervical Dystonia Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cervical Dystonia Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Other
5.2 By Application - Global Cervical Dystonia Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Cervical Dystonia Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Cervical Dystonia Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Cervical Dystonia Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cervical Dystonia Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Cervical Dystonia Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Cervical Dystonia Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Cervical Dystonia Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Cervical Dystonia Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cervical Dystonia Therapeutics Revenue, 2017-2028
  6.3.2 US Cervical Dystonia Therapeutics Market Size, 2017-2028
  6.3.3 Canada Cervical Dystonia Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Cervical Dystonia Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cervical Dystonia Therapeutics Revenue, 2017-2028
  6.4.2 Germany Cervical Dystonia Therapeutics Market Size, 2017-2028
  6.4.3 France Cervical Dystonia Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Cervical Dystonia Therapeutics Market Size, 2017-2028
  6.4.5 Italy Cervical Dystonia Therapeutics Market Size, 2017-2028
  6.4.6 Russia Cervical Dystonia Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Cervical Dystonia Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Cervical Dystonia Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cervical Dystonia Therapeutics Revenue, 2017-2028
  6.5.2 China Cervical Dystonia Therapeutics Market Size, 2017-2028
  6.5.3 Japan Cervical Dystonia Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Cervical Dystonia Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Cervical Dystonia Therapeutics Market Size, 2017-2028
  6.5.6 India Cervical Dystonia Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cervical Dystonia Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Cervical Dystonia Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Cervical Dystonia Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cervical Dystonia Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Cervical Dystonia Therapeutics Market Size, 2017-2028
  6.7.3 Israel Cervical Dystonia Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Cervical Dystonia Therapeutics Market Size, 2017-2028
  6.7.5 UAE Cervical Dystonia Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Allergan
  7.1.1 Allergan Corporate Summary
  7.1.2 Allergan Business Overview
  7.1.3 Allergan Cervical Dystonia Therapeutics Major Product Offerings
  7.1.4 Allergan Cervical Dystonia Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Allergan Key News
7.2 Eisai
  7.2.1 Eisai Corporate Summary
  7.2.2 Eisai Business Overview
  7.2.3 Eisai Cervical Dystonia Therapeutics Major Product Offerings
  7.2.4 Eisai Cervical Dystonia Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Eisai Key News
7.3 Ipsen Pharma
  7.3.1 Ipsen Pharma Corporate Summary
  7.3.2 Ipsen Pharma Business Overview
  7.3.3 Ipsen Pharma Cervical Dystonia Therapeutics Major Product Offerings
  7.3.4 Ipsen Pharma Cervical Dystonia Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Ipsen Pharma Key News
7.4 Merz Pharma
  7.4.1 Merz Pharma Corporate Summary
  7.4.2 Merz Pharma Business Overview
  7.4.3 Merz Pharma Cervical Dystonia Therapeutics Major Product Offerings
  7.4.4 Merz Pharma Cervical Dystonia Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Merz Pharma Key News
7.5 US WorldMeds
  7.5.1 US WorldMeds Corporate Summary
  7.5.2 US WorldMeds Business Overview
  7.5.3 US WorldMeds Cervical Dystonia Therapeutics Major Product Offerings
  7.5.4 US WorldMeds Cervical Dystonia Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 US WorldMeds Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cervical Dystonia Therapeutics Market Opportunities & Trends in Global Market
Table 2. Cervical Dystonia Therapeutics Market Drivers in Global Market
Table 3. Cervical Dystonia Therapeutics Market Restraints in Global Market
Table 4. Key Players of Cervical Dystonia Therapeutics in Global Market
Table 5. Top Cervical Dystonia Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cervical Dystonia Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cervical Dystonia Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cervical Dystonia Therapeutics Product Type
Table 9. List of Global Tier 1 Cervical Dystonia Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cervical Dystonia Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cervical Dystonia Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cervical Dystonia Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cervical Dystonia Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cervical Dystonia Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cervical Dystonia Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cervical Dystonia Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Allergan Corporate Summary
Table 31. Allergan Cervical Dystonia Therapeutics Product Offerings
Table 32. Allergan Cervical Dystonia Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Eisai Corporate Summary
Table 34. Eisai Cervical Dystonia Therapeutics Product Offerings
Table 35. Eisai Cervical Dystonia Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Ipsen Pharma Corporate Summary
Table 37. Ipsen Pharma Cervical Dystonia Therapeutics Product Offerings
Table 38. Ipsen Pharma Cervical Dystonia Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Merz Pharma Corporate Summary
Table 40. Merz Pharma Cervical Dystonia Therapeutics Product Offerings
Table 41. Merz Pharma Cervical Dystonia Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. US WorldMeds Corporate Summary
Table 43. US WorldMeds Cervical Dystonia Therapeutics Product Offerings
Table 44. US WorldMeds Cervical Dystonia Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cervical Dystonia Therapeutics Segment by Type in 2021
Figure 2. Cervical Dystonia Therapeutics Segment by Application in 2021
Figure 3. Global Cervical Dystonia Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cervical Dystonia Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cervical Dystonia Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cervical Dystonia Therapeutics Revenue in 2021
Figure 8. By Type - Global Cervical Dystonia Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cervical Dystonia Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cervical Dystonia Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cervical Dystonia Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cervical Dystonia Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cervical Dystonia Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cervical Dystonia Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cervical Dystonia Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cervical Dystonia Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Allergan Cervical Dystonia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Eisai Cervical Dystonia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Ipsen Pharma Cervical Dystonia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merz Pharma Cervical Dystonia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. US WorldMeds Cervical Dystonia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)